COPD

The CASCADE study found the biomarker of inflammation CRP associated with higher COPD symptom burden.

A new study sought to clarify conflicting findings on the impact of supplemental oxygen on exacerbations, hospitalization, and quality of life.

A new 5-question COPD assessment tool may help identify more serious disease earlier in the primary care setting.

The combination of heat and in-home air pollutants is dangerous, but also modifiable, say authors of a new study.

But are acute respiratory events associated with a decline in lung function in smokers without airway obstruction?

Responsiveness is consistent over the short term in individual patients but highly variable between patients.

Findings reported at the European Respiratory Society meeting point to "yes;" the effect size of decline in FEV1 may surprise you.

One-third of young adults (mid-20s) who had persistent asthma in childhood met GOLD criteria for obstructive lung disease.

Depression in COPD patients is one of the most common, yet least recognized comorbidities, with prevalence ranging from 17% to 44%.

Identifying risk, a promising mortality biomarker, and a new app for study recruitment-just a few of the latest developments in COPD research and patient care.

Vitamins C and E, in particular, have a beneficial effect on COPD risk and lung function in men, a new study found.

Effective asthma care requires attention to comorbidities, complications, and human characteristics of each patient. Speakers at CHEST 2015 described "the village."

New approaches discussed at CHEST 2015 ranged from the impact of bariatric surgery on asthma control to endobronchial valve placement in COPD.

In a well-attended session at CHEST 2015 a number of promising new therapies for treating COPD were reviewed by study authors.

COPD is one of the primary lung diseases seen in primary care. A CHEST 2015 panel session reinforced that treatment is often a risk/benefit balance.

Exacerbations of COPD often complicate CV outcomes. Two studies presented at CHEST 2015 looked at ways to refine risk factors for CV decline.

Here, during Respiratory Care Week, studies address safety concerns with new opioid use, relationships between PTSD and COPD, and a new smartphone app for better patient compliance.

ACOS is often first suspected in the primary care setting. Experts at CHEST 2015 reviewed the syndrome, who is at risk, and treatment challenges.

The GOLD criteria for COPD assessment have not lived up to their promise. Internationally agreed standards seem to be the real deal.

Undiagnosed lung disease in smokers, the impact of guidelines for community-acquired pneumonia in children, and climate change and asthma attacks make headlines in the respiratory news.

Obstructive, restrictive, or mixed airways disease? See what you know about asthma, COPD, and the test results used to diagnose each.

Respiratory disease is the main reason why patients visit primary care practices. This brief summary highlights the latest in research and patient care.

COPD challenges, asthma in children, smoking deaths-highlights of recent research findings in these key areas of respiratory disease.

Long-acting beta-agonists offer benefits in COPD. Not true for inhaled corticosteroids for most, it turns out.

There is emergent need to improve recognition and management of COPD in HIV-infected patients. Details here.

A new study shows that the risk of chronic obstructive pulmonary disease increases with obesity. Yet, the risk was increased in underweight persons as well.

For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.

Patients respond to 5 days of corticosteroid therapy just as well as to 14 days of therapy, according to a study.

Emphysematous cholecystitis is a rare condition that is the result of infection with Clostridium perfringens and other gas-producing organisms including Escherichia coli, Bacteroides fragilis, and Klebsiella species.

Older patients with chronic obstructive pulmonary disease are at higher risk for plaque formation in the carotid artery, increasing their risk of stroke.